≡ Risteys R6

Methods Changelog GitHub Contact & Feedback

Follow-up examination after treatment for malignant neoplasms

MESH PheWeb

No definition available.

Endpoint definition

↥
FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 Z08
Cause of death: ICD-10 Z08

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF4
Parent code in ICD-10 Z[0-1]

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 2010 1205 805
Unadjusted prevalence (%) 0.77 0.82 0.71
Mean age at first event (years) 62.97 59.93 67.53

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.51 [0.86, 2.65] 1.5e-1 353
15 years 0.01 2.09 [1.33, 3.26] 1.3e-3 320
5 years - - - -
1 year - - - -

Correlations

↥

Index endpoint: Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS – Follow-up examination after treatment for malignant neoplasms
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Follow-up examination after treatment for malignant neoplasms
after Follow-up examination after treatment for malignant neoplasms

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Follow-up examination after treatment for malignant neoplasms

↥